Answer
Topical clobetasone butyrate inhibits late-phase allergic reactions by decreasing mast-cell density, eosinophil chemotaxis and activation, cytokine production by lymphocytes, monocytes, mast cells and eosinophils, and arachidonic acid metabolism.
Sources for this answer
- Eumovate CreamGlaxoSmithKline UK · emc · SmPC §5.1 Pharmacodynamic properties · Version 13Document updated
Sources checked